Bio-Techne Corporation Shareholders' Equity for the year ending June 30, 2024: USD 2.07 B

Bio-Techne Corporation Shareholders' Equity is USD 2.07 B for the year ending June 30, 2024, a 5.20% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Bio-Techne Corporation Shareholders' Equity for the year ending June 30, 2023 was USD 1.97 B, a 15.61% change year over year.
  • Bio-Techne Corporation Shareholders' Equity for the year ending June 30, 2022 was USD 1.70 B, a 8.26% change year over year.
  • Bio-Techne Corporation Shareholders' Equity for the year ending June 30, 2021 was USD 1.57 B, a 13.76% change year over year.
  • Bio-Techne Corporation Shareholders' Equity for the year ending June 30, 2020 was USD 1.38 B, a 18.50% change year over year.
Key Data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory